DiscoverHypertrophic Cardiomyopathy Podcast SeriesHCM and New Pharmacological Agents
HCM and New Pharmacological Agents

HCM and New Pharmacological Agents

Update: 2022-06-27
Share

Description

Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes.  In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

HCM and New Pharmacological Agents

HCM and New Pharmacological Agents

American Heart Association